Alex has developed diverse content and methodological expertise in his fifteen years partnering with life science companies. This has involved leading a wide array of engagements with biotech, pharmaceutical, and diagnostics companies. Alex has unique expertise in oncology and patient-based forecasting that he has deployed working in both the U.S. and Europe supporting new product planning, portfolio strategy, launch readiness, commercialization strategy, and diligence support.
Prior to joining ClearView, Alex completed a B.S. & M.S. in Biology from the University of California at San Diego and an MBA from the Kellogg School of Management at Northwestern University. After transitioning away from the lab, he spent more than a decade assessing and improving R&D productivity for large pharma companies with the KMR Group and innovating in the commercial space as part of the Strategy & Portfolio Analysis team at IQVIA.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Ryan Tubman
Sam Ulin
Debbie Zhuang
Kristine Hyde
Sidnee Pinho
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Sarah Stapleton
Kai-Ming Pu
Kelsey Yardumian
Vini De Nadalal